More news: Military Use of Antipsychotics Threatens New Headaches for AstraZeneca, J | BNET Pharma Blog | BNET -- AstraZeneca (AZ) and Johnson & Johnson (JNJ) can expect a fresh round of PR headaches from a brewing Senate inquiry into military personnel taking antipsychotic and antidepressant drugs for post-traumatic stress disorder associated with combat in... Continue Reading →